On August 16, 2017, the FDA announced the discontinuation of Teva's QVAR (beclomethasone dipropionate HFA) inhalation aerosol due to business reasons. ... QVAR RediHaler uses a breath actuated metered dose inhaler, eliminating the need for hand breath coordination during inhalation.